Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Yaxiong Zhang; Jin Sheng; Shiyang Kang; Wenfeng Fang; Yue Yan; Zhihuang Hu; Shaodong Hong; Xuan Wu; Tao Qin; Wenhua Liang; Li Zhang

doi:10.1371/journal.pone.0107161

Loading metrics

Open Access

Peer-reviewed

Research Article

Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Yaxiong Zhang ,

Contributed equally to this work with: Yaxiong Zhang, Jin Sheng, Shiyang Kang

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Jin Sheng ,

Contributed equally to this work with: Yaxiong Zhang, Jin Sheng, Shiyang Kang

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Shiyang Kang ,

Contributed equally to this work with: Yaxiong Zhang, Jin Sheng, Shiyang Kang

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Wenfeng Fang,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Yue Yan,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Zhihuang Hu,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Shaodong Hong,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Xuan Wu,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Tao Qin,

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Wenhua Liang ,

* E-mail: liangwh@sysucc.org.cn (WL); zhangli6@mail.sysu.edu.cn (LZ)

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯
Li Zhang

* E-mail: liangwh@sysucc.org.cn (WL); zhangli6@mail.sysu.edu.cn (LZ)

Affiliation Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯

Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Yaxiong Zhang,
Jin Sheng,
Shiyang Kang,
Wenfeng Fang,
Yue Yan,
Zhihuang Hu,
Shaodong Hong,
Xuan Wu,
Tao Qin,
Wenhua Liang

Published: September 15, 2014
https://doi.org/10.1371/journal.pone.0107161

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Deletion mutation
Is the Subject Area "Deletion mutation" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Epidermal growth factor
Is the Subject Area "Epidermal growth factor" applicable to this article?

Thanks for your feedback.
Tyrosine kinase inhibitors
Is the Subject Area "Tyrosine kinase inhibitors" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.